MYGN Myriad Genetics Corp: Market Capitalization to Book Value Ratio

This daily price action for Myriad Genetics, Inc. (MYGN), which currently stands at 1.98, reflects the impact of pricing pressure from budget sequencing systems, forcing the business to develop unique diagnostic products. Myriad Genetics, Inc. (MYGN) relies on alliances with medical centers and pharmacists to implement personalized screenings. Colossal genetic data archives remain the foundation of its resilience, ensuring industry-standard status and a stable cash cow.

Myriad Genetics, Inc. (MYGN) - Market Capitalization to Book Value Ratio from 07/04/2022 to 10/28/2026

MYGN (Myriad Genetics Inc): analytical breakdowns and indicator data

- price and consensus price forecast:

Price Chart Myriad Genetics, Inc.|MYGN - Broker Consensus Forecast

- market capitalization data:

Market Capitalization Myriad Genetics Corp|MYGN - Real Price to Acquire Entire Company

- book capitalization data:

Book Value per Share Myriad Genetics|MYGN - Book Capitalization|Market Value to Book Value Ratio myriad.com|MYGN - Total Business Assets

- debt and liquidity data:

Total Debt to Capital Myriad Genetics, Inc.|MYGN - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Myriad Genetics Corp|MYGN - Company Cumulative Debt|Debt to Book Capitalization Ratio Myriad Genetics Corp|MYGN - Company Long-Term Loans and Borrowings|Company Current Liabilities Myriad Genetics

Fundamental valuation:MYGN (Myriad Genetics, Inc.)

Finished products of Myriad Genetics Inc

This indicator compares the market value of shares with net assets to determine the premium investors are willing to pay for the operating business. By analyzing the ratio of market capitalization to book value, one can assess the resilience of Myriad Genetics, Inc. (MYGN) to risks associated with changing Medicare conditions and the profitability of MyRisk tests, identifying either undervalued assets or a systemic liquidity crisis.

Main competitors